Face Lift Update: Johnson & Johnson Enters The Injectable Business

In a first-of-its-kind move, Johnson & Johnson, healthcare equipment and pharmaceuticals manufacturer has entered the dermal filler business and received permission from the FDA to market it.

Its new product Evolence is set to compete with old dermal filler stalwarts like Restylane and Juvederm and according to one spokesperson, could be offered at a similar or higher price than the rest. Another unique move associated with the product is the specialized training program offered by Johnson & Johnson to ensure proper administration.

Dermal fillers, a trusty face lift alternative, have been around for a long while now and Johnson & Johnson are set up against tough competition from the established brands. One point strongly against it is the use of porcine tendons in its manufacture.

Analysts point out that users prefer laboratory-made material for use as fillers in cosmetic surgery treatments. Additionally, Evolence has the staying power of only 6 months- same as the rest of the dermal fillers in the market.

It remains to be seen how the plastic surgery industry and patients will receive this new offering. The Plastic Surgery Institute of California, an advanced surgical institute offering face lift surgery and other cosmetic modifications has got its eyes open for Evolence.